Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Predictors of depressive symptoms before and after diagnostic procedures in women with abnormal Pap smear attending cervical cancer screening programme in Serbia

Predictors of depressive symptoms before and after diagnostic procedures in women with abnormal... INTRODUCTIONSerbia is one of the European countries with the highest incidence and mortality of cervical cancer over the last decade: Every year, there are about 1300 new cases and around 500 deaths from cervical cancer (Ilic & Ilic, 2018; International Agency for Research on Cancer, 2021). In 2013, Serbia began implementing an organised screening programme for cervical cancer (Ministry of Health of the Republic of Serbia, 2013).Cervical cancer is the fourth most frequent type of cancer among new cancer cases (accounting for 5.3% of all new cancer cases) and the sixth most common cause of cancer deaths (accounting for 4.7% of all cancer deaths) among women in Serbia in 2019 (Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, 2021). Cervical cancer is the most frequent gynaecological cancer in Serbia and also ranked first among all cancers in women aged 25–34 years in Serbia in 2019 (Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, 2021).Approximately 30 in every 100,000 women develop cervical cancer every year in Serbia (Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, 2021; International Agency for Research on Cancer, 2021). Less than one third of cervical cancers cases in Serbia were detected at an early stage, although the disease http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Care Wiley

Predictors of depressive symptoms before and after diagnostic procedures in women with abnormal Pap smear attending cervical cancer screening programme in Serbia

Download PDF
11 pages

Loading next page...
 
/lp/wiley/predictors-of-depressive-symptoms-before-and-after-diagnostic-dfz9xFhVtr
Publisher
Wiley
Copyright
© 2022 John Wiley & Sons Ltd
ISSN
0961-5423
eISSN
1365-2354
DOI
10.1111/ecc.13634
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONSerbia is one of the European countries with the highest incidence and mortality of cervical cancer over the last decade: Every year, there are about 1300 new cases and around 500 deaths from cervical cancer (Ilic & Ilic, 2018; International Agency for Research on Cancer, 2021). In 2013, Serbia began implementing an organised screening programme for cervical cancer (Ministry of Health of the Republic of Serbia, 2013).Cervical cancer is the fourth most frequent type of cancer among new cancer cases (accounting for 5.3% of all new cancer cases) and the sixth most common cause of cancer deaths (accounting for 4.7% of all cancer deaths) among women in Serbia in 2019 (Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, 2021). Cervical cancer is the most frequent gynaecological cancer in Serbia and also ranked first among all cancers in women aged 25–34 years in Serbia in 2019 (Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, 2021).Approximately 30 in every 100,000 women develop cervical cancer every year in Serbia (Institute of Public Health of Serbia “Dr Milan Jovanović Batut”, 2021; International Agency for Research on Cancer, 2021). Less than one third of cervical cancers cases in Serbia were detected at an early stage, although the disease

Journal

European Journal of Cancer Care – Wiley

Published: Sep 1, 2022

Keywords: cancer screening; depressive symptoms; diagnostic test; Papanicolaou smear

References

  • Psychological factors among Appalachian women with abnormal Pap results
    Adegboyega, A.; Dignan, M.; Sha, S.; Nkwonta, C.; Williams, L. B.
  • Anxiety and depression in later life: Co‐occurrence and communality of risk factors
    Beekman, A. T.; Beurs, E.; Balkom, A. J.; Deeg, D. J.; Dyck, R.; Tilburg, W.
  • Psychological response to cervical screening
    Bell, S.; Porter, M.; Kitchener, H.; Fraser, C.; Fisher, P.; Mann, E.
  • Intervention to improve follow‐up for abnormal Papanicolaou tests: A randomized clinical trial
    Breitkopf, C. R.; Dawson, L.; Grady, J. J.; Breitkopf, D. M.; Nelson‐Becker, C.; Snyder, R. R.
  • Can pre‐colposcopy sessions reduce anxiety at the time of colposcopy? A prospective randomised study
    Byrom, J.; Clarke, T.; Neale, J.; Dunn, P. D.; Hughes, G. M.; Redman, C. W.; Pitts, M.
  • Understanding barriers for adherence to follow‐up care for abnormal Pap tests
    Eggleston, K. S.; Coker, A. L.; Das, I. P.; Cordray, S. T.; Luchok, K. J.
  • Posttraumatic stress, anxiety and depression following miscarriage and ectopic pregnancy: A multicenter, prospective, cohort study
    Farren, J.; Jalmbrant, M.; Falconieri, N.; Mitchell‐Jones, N.; Bobdiwala, S.; Al‐Memar, M.; Tapp, S.; Calster, B.; Wynants, L.; Timmerman, D.; Bourne, T.
  • Emotional reactions in women attending a UK colposcopy clinic
    Gath, D. H.; Hallam, N.; Mynors‐Wallis, L.; Day, A.; Bond, S. A.
  • Health‐related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: An observational study
    Heinonen, A.; Tapper, A. M.; Leminen, A.; Sintonen, H.; Roine, R. P.
  • A 2‐year follow‐up study of anxiety and depression in women referred for colposcopy after an abnormal cervical smear
    Hellsten, C.; Sjöström, K.; Lindqvist, P. G.
  • Psychosocial barriers to follow‐up adherence after an abnormal cervical cytology test result among low‐income, inner‐city women
    Hui, S. K.; Miller, S. M.; Wen, K. Y.; Fang, Z.; Li, T.; Buzaglo, J.; Hernandez, E.
  • Reliability and validity of the Center for Epidemiologic Studies Depression (CES‐D) scale in Serbian women with abnormal Papanicolaou smear results
    Ilic, I.; Babic, G.; Dimitrijevic, A.; Ilic, M.; Sipetic Grujicic, S.
  • Psychological distress among women with abnormal pap smear results in Serbia: Validity and reliability of the Cervical Dysplasia Distress Questionnaire
    Ilic, I.; Babic, G.; Dimitrijevic, A.; Ilic, M.; Sipetic Grujicic, S.
  • Internal consistency and validity of the Hospital Anxiety and Depression Scale (HADS) in women with abnormal Pap smear in Serbia
    Ilic, I.; Babic, G.; Dimitrijevic, A.; Ilic, M.; Sipetic Grujicic, S.
  • Cancer mortality in Serbia, 1991‐2015: An age‐period‐cohort and joinpoint regression analysis
    Ilic, M.; Ilic, I.
  • Hormone‐related factors and post‐menopausal onset depression: Results from KNHANES (2010‐2012)
    Jung, S. J.; Shin, A.; Kang, D.
  • Recent Pap tests among Canadian women: Is depression a barrier to cervical cancer screening?
    Kaida, A.; Colman, I.; Janssen, P. A.
  • Significance of the Ki‐67 proliferation index in the assessment of the therapeutic response to cisplatin‐based chemotherapy in patients with advanced cervical cancer
    Krtinic, D.; Zivadinovic, R.; Jovic, Z.; Pesic, S.; Mihailovic, D.; Ristic, L.; Cvetanovic, A.; Todorovska, I.; Zivkovic, N.; Rankovic, G. N.; Stokanovic, D.; Zivadinovic, B.; Trandafilovic, M.; Apostolovic, M. A.; Golubovic, M.; Zivadinovic, A.
  • Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test
    Kyrgiou, M.; Kalliala, I. E.; Mitra, A.; Fotopoulou, C.; Ghaem‐Maghami, S.; Martin‐Hirsch, P. P.; Cruickshank, M.; Arbyn, M.; Paraskevaidis, E.
  • Reducing loss‐to‐follow‐up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow‐up protocol and economic incentives
    Marcus, A. C.; Kaplan, C. P.; Crane, L. A.; Berek, J. S.; Bernstein, G.; Gunning, J. E.; McClatchey, M. W.
  • Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause
    Marsh, W. K.; Bromberger, J. T.; Crawford, S. L.; Leung, K.; Kravitz, H. M.; Randolph, J. F.; Joffe, H.; Soares, C. N.
  • Patient preference for the management of mildly abnormal Papanicolaou smears
    Meana, M.; Stewart, D. E.; Lickrish, G. M.; Murphy, J.; Rosen, B.
  • Cancer in rural versus urban populations: A review
    Monroe, A. C.; Ricketts, T. C.; Savitz, L. A.
  • Psychological impact, support and information needs for women with an abnormal Pap smear: Comparative results of a questionnaire in three European countries
    Monsonego, J.; Cortes, J.; Silva, D. P.; Jorge, A. F.; Klein, P.
  • Factors associated with a positive depression screen after a miscarriage
    Mutiso, S. K.; Murage, A.; Mwaniki, A. M.
  • Adverse psychological outcomes following colposcopy and related procedures: A systematic review
    O'Connor, M.; Gallagher, P.; Waller, J.; Martin, C. M.; O'Leary, J. J.; Sharp, L.
  • Understanding women's differing experiences of distress after colposcopy: A qualitative interview study
    O'Connor, M.; Waller, J.; Gallagher, P.; Martin, C. M.; O'Leary, J. J.; D'Arcy, T.; Prendiville, W.; Flannelly, G.; Sharp, L.
  • Inadequate follow‐up for abnormal Pap smears in an urban population
    Peterson, N. B.; Han, J.; Freund, K. M.
  • Cervical cancer in the screening era: Who fell victim in spite of successful screening programs?
    Pettersson, B. F.; Hellman, K.; Vaziri, R.; Andersson, S.; Hellström, A. C.
  • Depressive symptom burden as a barrier to screening for breast and cervical cancers
    Pirraglia, P. A.; Sanyal, P.; Singer, D. E.; Ferris, T. G.
  • The CES‐D Scale: A self‐report depression scale for research in the general population
    Radloff, L. S.
  • The psychological impact of abnormal cytology and colposcopy
    Rogstad, K. E.
  • Association between subjective sleep quality and depression on immunocompetence in low‐income women at risk for cervical cancer
    Savard, J.; Miller, S. M.; Mills, M.; O'Leary, A.; Harding, H.; Douglas, S. D.; Mangan, C. E.; Belch, R.; Winokur, A.
  • Factors associated with psychological distress following colposcopy among women with low‐grade abnormal cervical cytology: A prospective study within the Trial Of Management of Borderline and Other Low‐grade Abnormal smears (TOMBOLA)
    Sharp, L.; Cotton, S.; Carsin, A. E.; Gray, N.; Thornton, A.; Cruickshank, M.; Little, J.
  • Long‐term psychosocial impact of alternative management policies in women with low‐grade abnormal cervical cytology referred for colposcopy: A randomised controlled trial
    Sharp, L.; Cotton, S.; Gray, N.; Avis, M.; Russell, I.; Walker, L.; Waugh, N.; Whynes, D.; Woolley, C.; Thornton, A.; Smart, L.; Cruickshank, M.; Little, J.
  • Psychosocial impact of alternative management policies for low‐grade cervical abnormalities: Results from the TOMBOLA randomised controlled trial
    Sharp, L.; Cotton, S.; Little, J.; Gray, N. M.; Cruickshank, M.; Smart, L.; Thornton, A.; Waugh, N.; Walker, L.
  • Distress after an abnormal Pap smear result: Scale development and psychometric validation
    Shinn, E.; Basen‐Engquist, K.; Le, T.; Hansis‐Diarte, A.; Bostic, D.; Martinez‐Cross, J.; Santos, A.; Follen, M.
  • Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020‐99: A modelling study
    Simms, K. T.; Steinberg, J.; Caruana, M.; Smith, M. A.; Lew, J. B.; Soerjomataram, I.; Castle, P. E.; Bray, F.; Canfell, K.
  • Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: Multicentre randomised controlled trial
  • 50 years of screening in the Nordic countries: Quantifying the effects on cervical cancer incidence
    Vaccarella, S.; Franceschi, S.; Engholm, G.; Lönnberg, S.; Khan, S.; Bray, F.
  • Does a “one‐stop” gynecology screening clinic for women in hereditary nonpolyposis colorectal cancer families have an impact on their psychological morbidity and perception of health?
    Wood, N. J.; Munot, S.; Sheridan, E.; Duffy, S. R.
  • Low health literacy, poor knowledge, and practice among Turkish women patients undergoing cervical cancer screening
    Yilmazel, G.
  • The hospital anxiety and depression scale
    Zigmond, A. S.; Snaith, R. P.